For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.
Adverse Events Module path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Groups
Study -> Results Section -> Adverse Events Module -> Serious Events
Study -> Results Section -> Adverse Events Module -> Other Events
| Title | Description | Deaths # Affected | Deaths # At Risk | Serious # Affected | Serious # At Risk | Other # Affected | Other # At Risk | View |
|---|---|---|---|---|---|---|---|---|
| Chemotherapy | Fludarabine/Rituximab followed by Lenalidomide Rituximab: 375 mg/m2 IV infusion Day 1 of each 28-day cycle for maximum of 6 cycles Fludarabine: 25 mg/m2 IV Days 1-5 of each 28-day cycle for maximum of 6 cycles Lenalidomide: 5-10 mg PO daily on Days 1-21 of each 28-day cycle for a maximum of 6 cycles | None | None | 1 | 22 | 13 | 22 | View |
| Term | Type | Organ System | Vocab | View |
|---|---|---|---|---|
| Fatal septic shock secondary to bacteremia | SYSTEMATIC_ASSESSMENT | Blood and lymphatic system disorders | None | View |
| Term | Type | Organ System | Vocab | View |
|---|---|---|---|---|
| grade 3/4 anemia | SYSTEMATIC_ASSESSMENT | Blood and lymphatic system disorders | None | View |
| grade 3/4 thrombocytopneia | SYSTEMATIC_ASSESSMENT | Blood and lymphatic system disorders | None | View |
| grade 1/2 thrombocytopenia | SYSTEMATIC_ASSESSMENT | Blood and lymphatic system disorders | None | View |
| grade 3/4 neutropenia | SYSTEMATIC_ASSESSMENT | Blood and lymphatic system disorders | None | View |
| grade 1/2 anemia | SYSTEMATIC_ASSESSMENT | Blood and lymphatic system disorders | None | View |
| grade 1/2 neutropenia | SYSTEMATIC_ASSESSMENT | Blood and lymphatic system disorders | None | View |